Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?

Diabetes, Obesity and Metabolism

Volumn 4, Issue 2, 2002, Pages 106-112

  Heller, S R ^a,d   Amiel, S A ^b   Evans, M L ^b   Kong, M F ^c   Macdonald, I A ^c   Peacey, S R ^e  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Glucose counterregulation; Hypoglycaemia; Insulin analogues; Intensive insulin therapy; Type 1 diabetes

Indexed keywords

ADRENALIN; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; HUMAN INSULIN; HYDROCORTISONE; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN; NEUTRAL INSULIN;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; HYPOTHESIS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 0036249903     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2002.00186.x     Document Type: Article

References (22)

1. Free insulin profiles in insulin-dependent diabetics treated with one or two insulin injections per day
2. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in non-diabetic humans
3. Intermittent hypoglycemia impairs glucose counterregulation
4. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus
5. Hypoglycemia
6. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes
7. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro
8. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy
9. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM
10. Restoration of hypoglycaemia unawareness in patients with long-duration insulin-dependent diabetes
11. Reversal of hypoglycemia unawareness, but not counterregulation, in IDDM
12. Prolonged but partial impairment of the hypoglycaemic physiological response following short-term hypoglycaemia in normal subjects
13. The assay of the catecholamine content of small volumes of human plasma
14. The effect of intravenous lactate on cerebral function during hypoglycaemia
15. Diabetic Hypoglycaemia
16. Unreliability of reports of hypoglycaemia by diabetic patients
17. Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes
18. Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin
19. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus
20. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release
21. Long-term intensive treatment of Type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtimes
22. Long-acting insulin analogs